Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) Debt to Equity (2019 - 2026)

Cresco Labs filings provide 8 years of Debt to Equity readings, the most recent being $1.73 for Q1 2026.

  • On a quarterly basis, Debt to Equity changed N/A to $1.73 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.73, a N/A change, with the full-year FY2025 number at $1.66, changed N/A from a year prior.
  • Debt to Equity hit $1.73 in Q1 2026 for Cresco Labs, up from $1.66 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.73 in Q1 2026 to a low of $0.0 in Q1 2022.
  • Median Debt to Equity over the past 5 years was $1.19 (2024), compared with a mean of $1.1.
  • Biggest five-year swings in Debt to Equity: soared 78252.66% in 2023 and later grew 19.29% in 2024.
  • Cresco Labs' Debt to Equity stood at $0.83 in 2022, then skyrocketed by 43.38% to $1.19 in 2023, then rose by 15.43% to $1.37 in 2024, then increased by 20.97% to $1.66 in 2025, then increased by 4.31% to $1.73 in 2026.
  • The last three reported values for Debt to Equity were $1.73 (Q1 2026), $1.66 (Q4 2025), and $1.37 (Q3 2024) per Business Quant data.